Early detection opens the door to intervention via noninvasive neuromodulation for those with treatment-resistant symptoms of psychotic disorders like schizophrenia.

How can caregivers be expected to hold the grief of their patients, and their patients’ families, when they are grieving themselves? That was the question addressed at a recent panel discussion at Vanderbilt.

His NIH-supported clinical neuroscience research program concentrates on late-life depression, focusing on neurobiological factors influencing acute and long-term outcomes.

Jennifer Vega, PhD, a cognitive neuroscientist and research instructor in the Department of Psychiatry and Behavioral Sciences, has received a 2024 National Comprehensive Cancer Network Foundation Young Investigator Award.

Mary Pawlikowski, MA, MEd, PsyDABD, president of Vanderbilt Psychiatric Hospital and Vanderbilt Behavioral Health, will retire at the end of the fiscal year. A search will begin for the hospital’s new executive director.

Vanderbilt's Heather Burrell Ward, MD, has received a five-year, $928,000 grant from the National Institute on Drug Abuse to test whether an externally applied magnetic field can reduce nicotine craving in people with schizophrenia.

In a new study across three major U.S. health care systems, researchers developed and tested algorithms to predict who will develop bipolar disorder.